Literature DB >> 30277812

Sepsis Therapies: Insights from Population Health to Cellular Therapies and Genomic Medicine.

Emanuele Rezoagli1, Bairbre McNicholas1, Peter Moran1, John G Laffey1.   

Abstract

Mesh:

Year:  2018        PMID: 30277812      PMCID: PMC7212795          DOI: 10.1164/rccm.201804-0782RR

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  25 in total

1.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).

Authors:  Mervyn Singer; Clifford S Deutschman; Christopher Warren Seymour; Manu Shankar-Hari; Djillali Annane; Michael Bauer; Rinaldo Bellomo; Gordon R Bernard; Jean-Daniel Chiche; Craig M Coopersmith; Richard S Hotchkiss; Mitchell M Levy; John C Marshall; Greg S Martin; Steven M Opal; Gordon D Rubenfeld; Tom van der Poll; Jean-Louis Vincent; Derek C Angus
Journal:  JAMA       Date:  2016-02-23       Impact factor: 56.272

2.  Antibiotics for Sepsis: Does Each Hour Really Count, or Is It Incestuous Amplification?

Authors:  Mervyn Singer
Journal:  Am J Respir Crit Care Med       Date:  2017-10-01       Impact factor: 21.405

Review 3.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.

Authors:  Mitchell M Levy; Mitchell P Fink; John C Marshall; Edward Abraham; Derek Angus; Deborah Cook; Jonathan Cohen; Steven M Opal; Jean-Louis Vincent; Graham Ramsay
Journal:  Crit Care Med       Date:  2003-04       Impact factor: 7.598

4.  Why have clinical trials in sepsis failed?

Authors:  John C Marshall
Journal:  Trends Mol Med       Date:  2014-02-24       Impact factor: 11.951

5.  The Timing of Early Antibiotics and Hospital Mortality in Sepsis.

Authors:  Vincent X Liu; Vikram Fielding-Singh; John D Greene; Jennifer M Baker; Theodore J Iwashyna; Jay Bhattacharya; Gabriel J Escobar
Journal:  Am J Respir Crit Care Med       Date:  2017-10-01       Impact factor: 21.405

6.  Revised National Estimates of Emergency Department Visits for Sepsis in the United States.

Authors:  Henry E Wang; Allison R Jones; John P Donnelly
Journal:  Crit Care Med       Date:  2017-09       Impact factor: 7.598

7.  Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis.

Authors:  Shirley H J Mei; Jack J Haitsma; Claudia C Dos Santos; Yupu Deng; Patrick F H Lai; Arthur S Slutsky; W Conrad Liles; Duncan J Stewart
Journal:  Am J Respir Crit Care Med       Date:  2010-06-17       Impact factor: 21.405

8.  Mesenchymal stem cells ameliorate sepsis-associated acute kidney injury in mice.

Authors:  Cong-juan Luo; Fu-jian Zhang; Li Zhang; Yan-qiu Geng; Qing-gang Li; Quan Hong; Bo Fu; Fei Zhu; Shao-yuan Cui; Zhe Feng; Xue-feng Sun; Xiang-mei Chen
Journal:  Shock       Date:  2014-02       Impact factor: 3.454

9.  Genome-wide association study of survival from sepsis due to pneumonia: an observational cohort study.

Authors:  Anna Rautanen; Tara C Mills; Anthony C Gordon; Paula Hutton; Michael Steffens; Rosamond Nuamah; Jean-Daniel Chiche; Tom Parks; Stephen J Chapman; Emma E Davenport; Katherine S Elliott; Julian Bion; Peter Lichtner; Thomas Meitinger; Thomas F Wienker; Mark J Caulfield; Charles Mein; Frank Bloos; Ilona Bobek; Paolo Cotogni; Vladimir Sramek; Silver Sarapuu; Makbule Kobilay; V Marco Ranieri; Jordi Rello; Gonzalo Sirgo; Yoram G Weiss; Stefan Russwurm; E Marion Schneider; Konrad Reinhart; Paul A H Holloway; Julian C Knight; Chris S Garrard; James A Russell; Keith R Walley; Frank Stüber; Adrian V S Hill; Charles J Hinds
Journal:  Lancet Respir Med       Date:  2014-12-18       Impact factor: 30.700

10.  Carbon Monoxide Improves Efficacy of Mesenchymal Stromal Cells During Sepsis by Production of Specialized Proresolving Lipid Mediators.

Authors:  Konstantin Tsoyi; Sean R R Hall; Jesmond Dalli; Romain A Colas; Sailaja Ghanta; Bonna Ith; Anna Coronata; Laura E Fredenburgh; Rebecca M Baron; Augustine M K Choi; Charles N Serhan; Xiaoli Liu; Mark A Perrella
Journal:  Crit Care Med       Date:  2016-12       Impact factor: 7.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.